SCHEMBL7022937

SCHEMBL7022937

c1cnc2c(c1)C[N]c1ccccc1O2

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ABCC4 O15439 1/20 0.37
PTGS1 P23219 1/20 0.37
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
SHMT2 P34897 1/20 0.34
ADRA2A P08913 1/20 0.33
DRD4 P21917 1/20 0.33
HTR2A P28223 1/20 0.33
GAA P10253 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
LMNA P02545 1/20 0.32
LTA4H P09960 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1648508 0.77 MAOA (0.59) ABCC4PTGS1MAOAMAOBSHMT2
SCHEMBL31151882 0.77 MAOA (0.59) ABCC4PTGS1MAOAMAOBSHMT2
SCHEMBL6616615 0.71 GAA (0.64) ABCC4PTGS1MAOAMAOBGAA
SCHEMBL5033603 0.70
SCHEMBL8113246 0.69 ABCC4 (0.40) ABCC4PTGS1MAOAMAOBSHMT2
SCHEMBL19821094 0.69 ABCC4 (0.40) ABCC4PTGS1SHMT2
SCHEMBL30317423 0.69 CA12 (0.38) MAOAMAOBTP53MAPTLMNA
SCHEMBL11541615 0.69 CA12 (0.38) MAOAMAOBTP53MAPTLMNA
SCHEMBL7339970 0.68 GAA (0.64) ABCC4PTGS1MAOAMAOBSHMT2
SCHEMBL3523540 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1051415-B1 BENZAMIDE DERIVATIVES AS VASOPRESSIN ANTAGONISTS FUJISAWA PHARMACEUTICAL CO (JP) 2003-09-24 EP disclosed
US-6495542-B1 SUCH AS 2-METHOXY-N-(2-METHYL-1H-BENZIMIDAZOL-4-YL)-4-(2,3,4,5-TETRAHYDRO-5-OXO-1H-1-BENZAZEPIN-1-YL)CARBONYL-BENZAM IDE; HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-12-17 US disclosed